In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients.

[1]  C. Schiff,et al.  Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the VH and VK families , 1991, Clinical and experimental immunology.

[2]  N. Brousse,et al.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. , 1990, The Journal of clinical investigation.

[3]  G. Rice,et al.  Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism , 1990, The Journal of experimental medicine.

[4]  S. Tonegawa,et al.  Self-tolerance to transgenic γδ T cells by intrathymic inactivation , 1990, Nature.

[5]  S. Suster,et al.  Histology of the normal thymus. , 1990, The American journal of surgical pathology.

[6]  M. Peuchmaur,et al.  IL-2 mRNA expression in Tac-positive malignant lymphomas. , 1990, The American journal of pathology.

[7]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[8]  R. Crawford,et al.  Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4. , 1989, Journal of immunology.

[9]  W. Karpus,et al.  CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis. , 1989, Journal of immunology.

[10]  S. Carding,et al.  In vivo administration of interleukin 1 elicits increased Ia antigen expression on B cells through the induction of interleukin 4 , 1989, European journal of immunology.

[11]  F. Ramsdell,et al.  A nondeletional mechanism of thymic self tolerance. , 1989, Science.

[12]  A. Mantovani,et al.  Cytokines as communication signals between leukocytes and endothelial cells. , 1989, Immunology today.

[13]  G. Kitas,et al.  Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and by human CD4+ T cell clones. , 1989, Journal of immunology.

[14]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[15]  K. Kayser,et al.  Expression of cortical and medullary thymic epithelial antigens in thymomas. An immunohistological study of 14 cases including a characterization of the lymphocytic compartment , 1989, Histopathology.

[16]  J. West,et al.  A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines , 1989, European journal of immunology.

[17]  H. Wekerle,et al.  Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. , 1989, The Journal of clinical investigation.

[18]  S. Rosati,et al.  Macrophages and interdigitating reticulum cells in normal thymus and in thymoma: an immunohistochemical study , 1989, Histopathology.

[19]  M. Auffredou,et al.  Glucocorticosteroid‐dependent synergy between interleukin 1 and interleukin 6 for human B lymphocyte differentiation , 1988, European journal of immunology.

[20]  J. Lindstrom,et al.  Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis. , 1988, Journal of immunology.

[21]  M. Lipinski,et al.  Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas , 1988, International journal of cancer.

[22]  P. Debré,et al.  Induction of differentiation in human leukemic b cells by interleukin 2 alone: differential effect on the expression of μ and j chain genes , 1988, European journal of immunology.

[23]  J. Ghrayeb,et al.  Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblasts , 1988, The Journal of experimental medicine.

[24]  D. Huang,et al.  Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. , 1988, The American journal of pathology.

[25]  M. Wainberg,et al.  Infection of human thymic epithelial cells by human cytomegalovirus and other viruses: effect on secretion of interleukin 1-like activity. , 1988, Clinical and experimental immunology.

[26]  H. Müller-Hermelink,et al.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. , 1988, The Journal of clinical investigation.

[27]  A. Zlotnik,et al.  Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1). , 1988, Journal of immunology.

[28]  S. Berrih-Aknin,et al.  The Role of the Thymus in Myasthenia Gravis: Immunohistological and Immunological Studies in 115 Cases a , 1987, Annals of the New York Academy of Sciences.

[29]  P. Scheurich,et al.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. , 1987, Journal of immunology.

[30]  K. Krolick,et al.  Analysis of helper-T-cell function by acetylcholine receptor-reactive cell lines of defined AChR-subunit specificity. , 1987, Cellular immunology.

[31]  P. Scheurich,et al.  Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. , 1987, Journal of immunology.

[32]  T. Tursz,et al.  Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Finkelman,et al.  Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. , 1986, Journal of immunology.

[34]  P. Sehgal,et al.  Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Hohlfeld,et al.  Myasthenia gravis , 1986, Neurology.

[36]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[37]  D. Lewis,et al.  Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation , 1986, The Journal of experimental medicine.

[38]  G. Janossy,et al.  Microenvironments in the normal thymus and the thymus in myasthenia gravis. , 1985, The American journal of pathology.

[39]  E. Reinherz,et al.  Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. , 1985, Journal of immunology.

[40]  R. Hohlfeld,et al.  Autoimmune human T lymphocytes specific for acetylcholine receptor , 1984, Nature.

[41]  P. Gaulard,et al.  Interleukin-2 and interferon-gamma production in follicular lymphomas. , 1991, American journal of clinical pathology.

[42]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.

[43]  H. Wekerle,et al.  Schwann cells and myasthenia gravis. Preferential uptake of soluble and membrane-bound AChR by normal and immortalized Schwann cells, and immunogenic presentation to AChR-specific T line lymphocytes. , 1990, The American journal of pathology.

[44]  T. Taniguchi.  Regulation of cytokine gene expression. , 1988, Annual review of immunology.

[45]  J. Bach,et al.  Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin , 1987, European journal of immunology.